PMID: 22567849May 10, 2012Paper

Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges

Genetika
A A ProzorovV N Danilenko

Abstract

The review summarizes the data on the Mycobacterium tuberculosis mutations that lead to multidrug resistance (MDR) to various antibiotics. MDR strains arose over the past 30 years as a variety of antituberculosis drugs were introduced in medicine, and they largely discount the results of chemotherapy for tuberculosis. The most dangerous of them are strains with extensive drug resistance (XDR), which are resistant to four or five different drugs on average. The molecular mechanisms that make a strain resistant are considered. XDR and MDR strains result from successive and usually independent resistance mutations, which arise in various regions of the mycobacterial genome. In addition, the formation of resistant strains is affected by the phenomenon of tolerance and mycobacterial latency in infected tissues.

References

Mar 1, 1995·Antimicrobial Agents and Chemotherapy·N HonoréS T Cole
Oct 15, 1994·FEMS Microbiology Letters·V Jarlier, H Nikaido
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·N Honoré, S T Cole
Mar 25, 1998·Journal of Medical Microbiology·F A Drobniewski, S M Wilson
May 16, 1998·Trends in Microbiology·N M ParrishW R Bishai
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A E DeBarberC E Barry
Feb 2, 2002·The Journal of Biological Chemistry·Tommaso A VannelliPaul R Ortiz de Montellano
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·R BroschS T Cole
May 14, 2003·Archives of Internal Medicine·Elizabeth L CorbettChristopher Dye
May 23, 2003·Antimicrobial Agents and Chemotherapy·Daiva BakonytePetras Stakenas
Jan 22, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·O S ToungoussovaG Bjune
Jun 18, 2004·Emerging Infectious Diseases·Helen Suzanne CoxMohammed Aziz
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Maria Rosalia PascaGiovanna Riccardi
Jan 13, 2005·British Journal of Pharmacology·Lee JiaMarina Protopopova
Jan 28, 2005·Antimicrobial Agents and Chemotherapy·Courtney E MausThomas M Shinnick
Feb 19, 2005·Nucleic Acids Research·Deo Prakash Pandey, Kenn Gerdes
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Courtney E MausThomas M Shinnick
Aug 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Rowan P MorrisCharles J Thompson
Oct 5, 2005·PLoS Pathogens·M Cristina GutierrezVeronique Vincent
Nov 1, 2005·Trends in Biochemical Sciences·Lieven ButsRemy Loris
Jan 21, 2006·Science·Vanessa M D'CostaGerard D Wright
Jan 28, 2006·FEMS Microbiology Reviews·Edda De RossiGiovanna Riccardi
Jun 9, 2006·Trends in Microbiology·Liem Nguyen, Charles J Thompson
Jul 18, 2006·The Journal of Infectious Diseases·Matteo ZignolChristopher Dye

❮ Previous
Next ❯

Citations

Sep 7, 2016·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Gisele S S FirminoJosane A Lessa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.